Question 1

Has Philip Lowry, MD received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $147,065 in general payments to Philip Lowry, MD across 65 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Philip Lowry, MD did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Philip Lowry, MD come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
E.r. Squibb & Sons, L.L.C.	18	$95,037
Macrogenics, Inc.	9	$14,307
Incyte Corporation	12	$11,474
AbbVie	11	$11,300
F. Hoffmann-la Roche AG	8	$7,750
Bayer	3	$3,550
Puma Biotechnology, Inc.	2	$2,174
AstraZeneca	1	$1,462
Gilead	1	$12

Drug	Claims	Cost to plans & patients
Abiraterone Acetate	22	$63,731
EliquisApixaban	46	$43,352
XareltoRivaroxaban	13	$9,826
Tamoxifen Citrate	16	$900
Anastrozole	28	$801
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	22	$684
Fentanyl	13	$655
Ondansetron OdtOndansetron	26	$615
Bicalutamide	18	$548
Prochlorperazine Maleate	35	$513
Dexamethasone	46	$489
Hydroxyurea	27	$452
Ondansetron Hcl	12	$431
Oxycodone Hcl	22	$387
Acyclovir	19	$324

Philip Lowry, MD

Payments from drug & device makers

Who reported the general payments

How this compares

Medicare billing

Most prescribed under Part D

Other hematology & oncology in Bryan